CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

Alajati A, D'Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, Revandkar A, Bolis M, Theurillat JP, Guccini I, Losa M, Calcinotto A, De Bernardis G, Pasquini E, D'Antuono R, Sharp A, Figueiredo I, Nava Rodrigues D, Welti J, Gil V, Yuan W, Vlajnic T, Bubendorf L, Chiorino G, Gnetti L, Torrano V, Carracedo A, Camplese L, Hirabayashi S, Canato E, Pasut G, Montopoli M, Ruschoff JH, Wild P, Moch H, De Bono J, Alimonti A
J Clin Invest. 2020 May 1;130(5):2435-2450. doi: 10.1172/JCI131133. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.